96 related articles for article (PubMed ID: 19796689)
1. Production of recombinant anthrax toxin receptor (ATR/CMG2) fused with human Fc in planta.
Andrianov V; Brodzik R; Spitsin S; Bandurska K; McManus H; Koprowski H; Golovkin M
Protein Expr Purif; 2010 Apr; 70(2):158-62. PubMed ID: 19796689
[TBL] [Abstract][Full Text] [Related]
2. Transient co-expression of post-transcriptional gene silencing suppressors for increased in planta expression of a recombinant anthrax receptor fusion protein.
Arzola L; Chen J; Rattanaporn K; Maclean JM; McDonald KA
Int J Mol Sci; 2011; 12(8):4975-90. PubMed ID: 21954339
[TBL] [Abstract][Full Text] [Related]
3. [Expression of ATR-Fc fusion protein in CHO cells].
Gao LH; Hu XW; Chen W; Xu JJ; Zhao J; Chen HP
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):826-31. PubMed ID: 16285529
[TBL] [Abstract][Full Text] [Related]
4. Recombinant anthrax toxin receptor-Fc fusion proteins produced in plants protect rabbits against inhalational anthrax.
Wycoff KL; Belle A; Deppe D; Schaefer L; Maclean JM; Haase S; Trilling AK; Liu S; Leppla SH; Geren IN; Pawlik J; Peterson JW
Antimicrob Agents Chemother; 2011 Jan; 55(1):132-9. PubMed ID: 20956592
[TBL] [Abstract][Full Text] [Related]
5. Expression, Purification, and Biophysical Characterization of a Secreted Anthrax Decoy Fusion Protein in Nicotiana benthamiana.
Karuppanan K; Duhra-Gill S; Kailemia MJ; Phu ML; Lebrilla CB; Dandekar AM; Rodriguez RL; Nandi S; McDonald KA
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28054967
[TBL] [Abstract][Full Text] [Related]
6. Recombinant HSA-CMG2 Is a Promising Anthrax Toxin Inhibitor.
Li L; Guo Q; Liu J; Zhang J; Yin Y; Dong D; Fu L; Xu J; Chen W
Toxins (Basel); 2016 Jan; 8(1):. PubMed ID: 26805881
[TBL] [Abstract][Full Text] [Related]
7. Interactions between anthrax toxin receptors and protective antigen.
Scobie HM; Young JA
Curr Opin Microbiol; 2005 Feb; 8(1):106-12. PubMed ID: 15694864
[TBL] [Abstract][Full Text] [Related]
8. Improving the anti-toxin abilities of the CMG2-Fc fusion protein with the aid of computational design.
Xi Y; Wu X; Gao L; Shao Y; Peng H; Chen H; Chen H; Hu X; Yue J
PLoS One; 2014; 9(8):e104674. PubMed ID: 25101992
[TBL] [Abstract][Full Text] [Related]
9. Identification of the cellular receptor for anthrax toxin.
Bradley KA; Mogridge J; Mourez M; Collier RJ; Young JA
Nature; 2001 Nov; 414(6860):225-9. PubMed ID: 11700562
[TBL] [Abstract][Full Text] [Related]
10. Human capillary morphogenesis protein 2 functions as an anthrax toxin receptor.
Scobie HM; Rainey GJ; Bradley KA; Young JA
Proc Natl Acad Sci U S A; 2003 Apr; 100(9):5170-4. PubMed ID: 12700348
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activities of TEM8-Fc: an engineered antibody-like molecule targeting tumor endothelial marker 8.
Duan HF; Hu XW; Chen JL; Gao LH; Xi YY; Lu Y; Li JF; Zhao SR; Xu JJ; Chen HP; Chen W; Wu CT
J Natl Cancer Inst; 2007 Oct; 99(20):1551-5. PubMed ID: 17925540
[TBL] [Abstract][Full Text] [Related]
12. The inhibition of the interaction between the anthrax toxin and its cellular receptor by an anti-receptor monoclonal antibody.
Li G; Qu Y; Cai C; Kong Y; Liu S; Zhang J; Zhao J; Fu L; Xu J; Chen W
Biochem Biophys Res Commun; 2009 Aug; 385(4):591-5. PubMed ID: 19486894
[TBL] [Abstract][Full Text] [Related]
13. Poly-gamma-d-glutamic acid and protective antigen conjugate vaccines induce functional antibodies against the protective antigen and capsule of Bacillus anthracis in guinea-pigs and rabbits.
Lee DY; Chun JH; Ha HJ; Park J; Kim BS; Oh HB; Rhie GE
FEMS Immunol Med Microbiol; 2009 Nov; 57(2):165-72. PubMed ID: 19732139
[TBL] [Abstract][Full Text] [Related]
14. Human-derived, plant-produced monoclonal antibody for the treatment of anthrax.
Hull AK; Criscuolo CJ; Mett V; Groen H; Steeman W; Westra H; Chapman G; Legutki B; Baillie L; Yusibov V
Vaccine; 2005 Mar; 23(17-18):2082-6. PubMed ID: 15755575
[TBL] [Abstract][Full Text] [Related]
15. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits.
Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C
Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of ELISA-reactive antibodies against anthrax protective antigen (PA), lethal factor (LF), and toxin-neutralising antibodies in serum of individuals vaccinated against anthrax with the PA-based UK anthrax vaccine.
Grunow R; Porsch-Ozcürümez M; Splettstoesser W; Buckendahl A; Hahn U; Beyer W; Böhm R; Huber M; vd Esche U; Bessler W; Frangoulidis D; Finke EJ
Vaccine; 2007 May; 25(18):3679-83. PubMed ID: 17287051
[TBL] [Abstract][Full Text] [Related]
17. Passive immunotherapy of Bacillus anthracis pulmonary infection in mice with antisera produced by DNA immunization.
Herrmann JE; Wang S; Zhang C; Panchal RG; Bavari S; Lyons CR; Lovchik JA; Golding B; Shiloach J; Lu S
Vaccine; 2006 Jul; 24(31-32):5872-80. PubMed ID: 16790303
[TBL] [Abstract][Full Text] [Related]
18. Recombinant viral-like particles of parvovirus B19 as antigen carriers of anthrax protective antigen.
Ogasawara Y; Amexis G; Yamaguchi H; Kajigaya S; Leppla SH; Young NS
In Vivo; 2006; 20(3):319-24. PubMed ID: 16724664
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen-immunoglobulin Fc fusion protein (CEA-Fc) for identification and activation of anti-CEA immunoglobulin-T-cell receptor-modified T cells, representative of a new class of Ig fusion proteins.
Ma Q; DeMarte L; Wang Y; Stanners CP; Junghans RP
Cancer Gene Ther; 2004 Apr; 11(4):297-306. PubMed ID: 15002034
[TBL] [Abstract][Full Text] [Related]
20. Stability of domain 4 of the anthrax toxin protective antigen and the effect of the VWA domain of CMG2 on stability.
Mamillapalli S; Miyagi M; Bann JG
Protein Sci; 2017 Feb; 26(2):355-364. PubMed ID: 27874231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
